Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Achilles Therapeutics Plc (NQ: ACHL )

1.017 -0.013 (-1.22%)
Streaming Delayed Price Updated: 3:51 PM EDT, Jun 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 35,934
Open 1.030
Bid (Size) 0.9800 (2)
Ask (Size) 1.030 (10)
Prev. Close 1.030
Today's Range 0.9700 - 1.040
52wk Range 0.7500 - 3.450
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Stocks With 1,000% Upside Potential
If you're an investor comfortable with speculative bets, analysts are price targeting these stocks with 1000% upside. 
Via InvestorPlace
Achilles Therapeutics: Q1 Earnings Insights
 
Via Benzinga

Performance

YTD
-3.10%
-3.10%
1 Month
+18.30%
+18.30%
3 Month
-6.66%
-6.66%
6 Month
-40.50%
-40.50%
1 Year
-58.98%
-58.98%

More News

Read More
Achilles Therapeutics Reports First Quarter 2023 Financial Results and Recent Business Highlights
From Achilles Therapeutics PLC
Via GlobeNewswire
Achilles Therapeutics’ New Immunogenicity Prediction Application of its AI-Powered PELEUS™ Platform Uniquely Identifies the Most Potent T Cell Antigens
From Achilles Therapeutics PLC
Via GlobeNewswire
Recap: Achilles Therapeutics Q2 Earnings
Via Benzinga
Achilles Therapeutics: Q1 Earnings Insights
Via Benzinga
Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
From Achilles Therapeutics PLC
Via GlobeNewswire
Achilles Therapeutics Announces Grant of US Patent Covering the Treatment of Patients with an Immunotherapy Targeting Neoantigens Based on Tumor HLA Status
From Achilles Therapeutics PLC
Via GlobeNewswire
Achilles Therapeutics to Present at Chardan’s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
From Achilles Therapeutics PLC
Via GlobeNewswire
Achilles Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Recent Business Highlights
From Achilles Therapeutics PLC
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Achilles Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Achilles Therapeutics PLC
Via GlobeNewswire
Achilles Therapeutics Presents Encouraging Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma at ESMO IO Congress 2022
From Achilles Therapeutics PLC
Via GlobeNewswire
Why UiPath Shares Are Trading Higher By Around 8%; Here Are 24 Stocks Moving Premarket
Via Benzinga
Achilles Therapeutics to Present Early Proof of Concept of Safety and Clinical Activity of Clonal Neoantigen Reactive T Cells at the ESMO Immuno-Oncology Annual Congress 2022
From Achilles Therapeutics PLC
Via GlobeNewswire
Achilles Therapeutics Announces Grant of US Patent on Immunotherapies Targeting Clonal Neoantigens Identified Using Proprietary Method
From Achilles Therapeutics PLC
Via GlobeNewswire
Achilles Therapeutics Reports Third Quarter 2022 Financial Results and Recent Business Highlights
From Achilles Therapeutics PLC
Via GlobeNewswire
Achilles Therapeutics Co-founder Professor Charles Swanton to Participate in Expert Roundtable Highlighting Pivotal Nature of Neoantigens as Targets in Cancer Cell Therapy
From Achilles Therapeutics PLC
Via GlobeNewswire
5 Value Stocks To Watch In The Healthcare Sector
Via Benzinga
5 Value Stocks In The Healthcare Sector
Via Benzinga
Why Qudian Shares Jumped Over 40%; Here Are 73 Biggest Movers From Yesterday
Via Benzinga
Tesla, Coinbase Global And 41 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why U.S. Stocks Are Trading Higher; Goldman Sachs Tops Q2 Views
Via Benzinga
5 Value Stocks To Watch In The Healthcare Sector
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.